IRIS Accounts Production v25.4.0.155 15601934 director 29.3.24 31.3.25 31.3.25 false true false false false iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 15601934 2024-03-28 15601934 2025-03-31 15601934 2024-03-29 2025-03-31 15601934 2024-03-28 15601934 ns15:EnglandWales 2024-03-29 2025-03-31 15601934 ns14:PoundSterling 2024-03-29 2025-03-31 15601934 ns10:Director1 2024-03-29 2025-03-31 15601934 ns10:PrivateLimitedCompanyLtd 2024-03-29 2025-03-31 15601934 ns10:Micro-entities 2024-03-29 2025-03-31 15601934 ns10:AuditExempt-NoAccountantsReport 2024-03-29 2025-03-31 15601934 ns10:SmallCompaniesRegimeForAccounts 2024-03-29 2025-03-31 15601934 ns10:FullAccounts 2024-03-29 2025-03-31 15601934 ns5:CurrentFinancialInstruments 2025-03-31 15601934 ns10:RegisteredOffice 2024-03-29 2025-03-31

REGISTERED NUMBER: 15601934 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS FOR THE PERIOD 29 MARCH 2024 TO 31 MARCH 2025

FOR

R MEDICAL LTD

| R MEDICAL LTD (REGISTERED NUMBER: 15601934) |

CONTENTS OF THE FINANCIAL STATEMENTS

for the Period 29 March 2024 to 31 March 2025

Page |

| Balance Sheet | 1 |

| R MEDICAL LTD (REGISTERED NUMBER: 15601934) |

BALANCE SHEET

31 March 2025

£ | £ |

| FIXED ASSETS | 1,189 |  |

| CURRENT ASSETS | 64,039 |  |  |

| CREDITORS

| Amounts falling due within one year | (22,152 | ) |

| NET CURRENT ASSETS | 41,887 |  |

| TOTAL ASSETS LESS CURRENT LIABILITIES | 43,076 |  |

| CAPITAL AND RESERVES | 43,076 |  |

NOTES TO THE FINANCIAL STATEMENTS

1. | STATUTORY INFORMATION

| R Medical Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

| Registered number: | 15601934

| Registered office: | 5 Clarence Road

| Harborne

| Birmingham

| West Midlands

| B17 9LA

| R MEDICAL LTD (REGISTERED NUMBER: 15601934) |

BALANCE SHEET - continued

31 March 2025

NOTES TO THE FINANCIAL STATEMENTS

2. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| These financial statements have been prepared in accordance with Financial Reporting Standard 105 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

| Turnover

| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

| Tangible fixed assets

| Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

| Stocks

| Inventories are valued at the lower of cost and net realizable value, after making due allowance for obsolete and slow moving items.

| Taxation

| Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

| Current or deferred taxation assets and liabilities are not discounted.

| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

| .

3. | AVERAGE NUMBER OF EMPLOYEES

| The average number of employees during the period was 1 .

| R MEDICAL LTD (REGISTERED NUMBER: 15601934) |

BALANCE SHEET - continued

31 March 2025

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 13 October 2025 and were signed by:

Dr. Zi Hao Reuel Heng - Director